DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Biosimilars - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022.
Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
The report profiles 71 companies including many key and niche players such as
- Amgen Inc. (US)
- Allergan Plc. (Ireland)
- Biocon Ltd. (India)
- Biopartners GmbH (Switzerland)
- Boehringer Ingelheim GmbH (Germany)
- Celltrion Inc. (South Korea)
- Cipla Ltd. (India)
- Cipla BioTec Private Ltd. (India)
- Dr. Reddy's Laboratories Ltd. (India)
- Eli Lilly and Company (US)
- EPIRUS Biopharmaceuticals, Inc. (US)
- Hospira, Inc. (US)
- Intas Biopharmaceuticals Ltd. (India)
- Merck KGaA (Germany)
- Mylan N.V. (US)
- Pfizer Inc. (US)
- Samsung Bioepis Co., Ltd. (Korea)
- Sandoz International GmbH (Germany)
- STADA Arzneimittel AG (Germany)
- Teva Pharmaceutical Industries Ltd. (Israel)
Key Topics Covered:
1. Market Overview
2. Recent Biosimilar Approvals And Pipeline Analysis
3. Market Dynamics & Trends
4. Global Biologics Market
5. Product Overview
6. Product Approvals/Introductions
7. Recent Industry Activity
8. Focus On Select Market Players
9. Global Market Perspective
Total Companies Profiled: 71 (including Divisions/Subsidiaries 77)
- The United States (15)
- Canada (1)
- Japan (3)
- Europe (25)
- - France (1)
- - Germany (8)
- - The United Kingdom (5)
- - Spain (1)
- - Rest of Europe (10)
- Asia-Pacific (Excluding Japan) (30)
- Latin America (1)
- Middle-East (2)
For more information about this report visit http://www.researchandmarkets.com/research/3j6l82/biosimilars
Related Topics: Biosimilars and Biosuperiors
